Passage Bio (NYSE:GFL) – Equities researchers at National Bank Financial increased their Q2 2020 earnings per share (EPS) estimates for Passage Bio in a report released on Wednesday, June 24th. National Bank Financial analyst R. Merer now anticipates that the company will earn ($0.14) per share for the quarter, up from their previous estimate of ($0.15). National Bank Financial currently has a “Outperform” rating on the stock. National Bank Financial also issued estimates for Passage Bio’s FY2021 earnings at ($0.41) EPS.
Several other research firms have also recently weighed in on GFL. Scotiabank started coverage on shares of Passage Bio in a report on Monday, March 30th. They set an “outperform” rating and a $23.00 price objective for the company. TD Securities boosted their price objective on shares of Passage Bio from $27.00 to $29.00 and gave the company a “hold” rating in a report on Friday, June 26th. BMO Capital Markets reaffirmed a “buy” rating on shares of Passage Bio in a report on Monday. Bank of America began coverage on shares of Passage Bio in a report on Monday, March 30th. They set a “neutral” rating for the company. Finally, JPMorgan Chase & Co. began coverage on shares of Passage Bio in a report on Monday, March 30th. They set an “overweight” rating and a $19.00 target price for the company. Six investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. The company currently has a consensus rating of “Buy” and an average price target of $23.05.
GFL opened at $18.77 on Monday. The firm’s 50 day moving average is $18.40. Passage Bio has a twelve month low of $11.92 and a twelve month high of $20.97.
Passage Bio (NYSE:GFL) last released its quarterly earnings data on Monday, May 11th. The company reported ($0.02) earnings per share for the quarter, beating the consensus estimate of ($0.35) by $0.33. The company had revenue of $694.42 million for the quarter, compared to analysts’ expectations of $632.34 million.
About Passage Bio
GFL Environmental Inc operates as a diversified environmental services company in North America. The company offers non-hazardous solid waste management, infrastructure and soil remediation, and liquid waste management services. Its solid waste management business line includes the collection, transportation, transfer, recycling, and disposal of non-hazardous solid waste for municipal, residential, and commercial and industrial customers.
Featured Story: What is Compound Interest?
Receive News & Ratings for Passage Bio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Passage Bio and related companies with MarketBeat.com's FREE daily email newsletter.